Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:GRAL.O 22 January 2026

GRAIL stock jumps as Galleri outlook and FDA filing timeline come back into focus

GRAIL stock jumps as Galleri outlook and FDA filing timeline come back into focus

GRAIL shares jumped 13.2% to $114.41 Thursday, hitting an intraday high of $118.50 amid investor focus on cash burn and 2026 growth targets. The company projects 2025 revenue of $147–$148 million and aims to cut cash burn to $274 million. Key milestones include a modular FDA submission in Q1 and major clinical trial readouts by mid-2026. Investors are also watching the closing of a $110 million Samsung investment.
22 January 2026
·

Stock Market Today

  • British American Tobacco Shares Seen Undervalued Despite 45.7% Rally
    March 20, 2026, 9:45 PM EDT. British American Tobacco (LSE:BATS) has surged 45.7% over the past year, trading near £43.11. Despite this strong rally, a Discounted Cash Flow (DCF) analysis suggests the stock remains undervalued by 37%, with an intrinsic value estimate of £68.41 per share. The company generated free cash flow of approximately £5.75 billion in the last twelve months, projected to grow to £9.5 billion by 2030. Its Price-to-Earnings (P/E) ratio stands at 12.17x, reflecting market caution amid concerns about regulation, product mix, and capital allocation. Recent short-term declines highlight potential risks, but investor interest persists fueled by the tobacco sector dynamics and British American Tobacco's balance of shareholder returns with investment needs.
Go toTop